Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-002979
Filing Date
2023-01-30
Accepted
2023-01-30 17:26:01
Documents
2
Period of Report
2023-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6329
2 EX-24 DOCUMENT attachment1.htm EX-24 4623
  Complete submission text file 0000899243-23-002979.txt   12322
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Issuer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address
Lee John Jui-Jen (Reporting) CIK: 0001844264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40030 | Film No.: 23569204